{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T15:09:57Z","timestamp":1751987397397},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,7,20]],"date-time":"2013-07-20T00:00:00Z","timestamp":1374278400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1007\/s00417-013-2422-4","type":"journal-article","created":{"date-parts":[[2013,7,19]],"date-time":"2013-07-19T04:53:38Z","timestamp":1374209618000},"page":"207-211","source":"Crossref","is-referenced-by-count":6,"title":["Paired responses to intravitreal bevacizumab in diabetic macular edema: predictors of response in the fellow eye"],"prefix":"10.1007","volume":"252","author":[{"given":"Peter A.","family":"Karth","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Wirostko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,7,20]]},"reference":[{"key":"2422_CR1","volume-title":"National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011","author":"Centers for Disease Control and Prevention","year":"2011","unstructured":"Centers for Disease Control and Prevention (2011) National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta"},{"key":"2422_CR2","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1001\/archopht.1984.01040030405011","volume":"102","author":"R Klein","year":"1984","unstructured":"Klein R, Klein BE, Moss SE, Davis MD, DeMets DL (1984) The Wisconsin epidemiologic study of diabetic retinopathy: III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 102:527\u2013532","journal-title":"Arch Ophthalmol"},{"key":"2422_CR3","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/S0161-6420(84)34102-1","volume":"91","author":"R Klein","year":"1984","unstructured":"Klein R, Klein BE, Moss SE, Davis MD, DeMets DL (1984) The Wisconsin epidemiologic study of diabetic retinopathy: IV. Diabetic macular edema. Ophthalmology 91:1464\u20131474","journal-title":"Ophthalmology"},{"issue":"6","key":"2422_CR4","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/S0161-6420(94)31217-6","volume":"101","author":"SE Moss","year":"1994","unstructured":"Moss SE, Klein R, Klein BE (1994) Ten-year incidence of visual loss in a diabetic population. Ophthalmology 101(6):1061\u20131070","journal-title":"Ophthalmology"},{"issue":"5","key":"2422_CR5","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1167\/iovs.09-4493","volume":"52","author":"L Pelosini","year":"2011","unstructured":"Pelosini L, Hull CC, Boyce JF, McHugh D, Stanford MR, Marshall J (2011) Optical coherence tomography may be used to predict visual acuity in patients with macular edema. Invest Ophthalmol Vis Sci 52(5):2741\u20132748","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"2422_CR6","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1159\/000313820","volume":"224","author":"MI Roh","year":"2010","unstructured":"Roh MI, Kim JH, Kwon OW (2010) Features of optical coherence tomography are predictive of visual outcomes after intravitreal bevacizumab injection for diabetic macular edema. Ophthalmologica 224(6):374\u2013380","journal-title":"Ophthalmologica"},{"issue":"1","key":"2422_CR7","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1089\/jop.2011.0070","volume":"28","author":"PC Wu","year":"2012","unstructured":"Wu PC, Lai CH, Chen CL, Kuo CN (2012) Optical coherence tomographic patterns in diabetic macula edema can predict the effects of intravitreal bevacizumab injection as primary. J Ocul Pharmacol Ther 28(1):59\u201364","journal-title":"J Ocul Pharmacol Ther"},{"issue":"3","key":"2422_CR8","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1159\/000330045","volume":"226","author":"M Kim","year":"2011","unstructured":"Kim M, Lee P, Kim Y, Yu SY, Kwak HW (2011) Effect of intravitreal bevacizumab based on optical coherence tomography patterns of diabetic macular edema. Ophthalmologica 226(3):138\u2013144","journal-title":"Ophthalmologica"},{"issue":"11","key":"2422_CR9","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.2337\/dc10-0493","volume":"33","author":"P Massin","year":"2010","unstructured":"Massin P, Bandello F, Garweg JG, Hansen LL, Harding SP, Larsen M, Mitchell P, Sharp D, Wolf-Schnurrbusch UE, Gekkieva M, Weichselberger A, Wolf S (2010) Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE study): a 12-month, randomized, controlled, double-masked, multicenter phase II study. Diabetes Care 33(11):2399\u20132405","journal-title":"Diabetes Care"},{"issue":"4","key":"2422_CR10","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.ophtha.2011.12.039","volume":"119","author":"QD Nguyen","year":"2012","unstructured":"Nguyen QD, Brown DM, Marcus DM, Boyer DS, Patel S, Feiner L, Gibson A, Sy J, Rundle AC, Hopkins JJ, Rubio RG, Ehrlich JS (2012) Ranibizumab for diabetic macular edema. Ophthalmology 119(4):789\u2013801","journal-title":"Ophthalmology"},{"issue":"10","key":"2422_CR11","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1016\/j.ophtha.2007.05.062","volume":"114","author":"IU Scott","year":"2007","unstructured":"Diabetic Retinopathy Clinical Research Network, Scott IU, Edwards AR, Beck RW, Bressler NM, Chan CK, Elman MJ, Friedman SM, Greven CM, Maturi RK, Pieramici DJ, Shami M, Singerman LJ, Stockdale CR (2007) A phase II randomized clinical trial of intravitreal bevacizumab for diabetic macular edema. Ophthalmology 114(10):1860\u20131867","journal-title":"Ophthalmology"},{"key":"2422_CR12","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jaapos.2009.03.006","volume":"13","author":"H Al-Dhibi","year":"2009","unstructured":"Al-Dhibi H, Khan AO (2009) Bilateral response following unilateral intravitreal bevacizumab injection in a child with uveitic cystoid macular edema. J AAPOS 13:400\u2013402","journal-title":"J AAPOS"},{"key":"2422_CR13","doi-asserted-by":"crossref","first-page":"591","DOI":"10.47102\/annals-acadmedsg.V37N7p591","volume":"37","author":"Z Wu","year":"2008","unstructured":"Wu Z, Sadda SR (2008) Effects on the contralateral eye after intravitreal bevacizumab and ranibizumab injections: a case report. Ann Acad Med Singap 37:591\u2013593","journal-title":"Ann Acad Med Singap"},{"key":"2422_CR14","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1600-0420.2007.01067.x","volume":"86","author":"C Shima","year":"2008","unstructured":"Shima C, Sakaguchi H, Gomi F, Kamei M, Ikuno Y, Oshima Y, Sawa M, Tsujikawa M, Kusaka S, Tano Y (2008) Complications in patients after intravitreal injection of bevacizumab. Acta Ophthalmol 86:372\u2013376","journal-title":"Acta Ophthalmol"},{"key":"2422_CR15","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1755-3768.2009.01842.x","volume":"90","author":"CH Meyer","year":"2012","unstructured":"Meyer CH, Krohne TU, Holz FG (2012) Concentrations of unbound bevacizumab in the aqueous of untreated fellow eyes after a single intravitreal injection in humans. Acta Ophthalmol 90:68\u201370","journal-title":"Acta Ophthalmol"},{"key":"2422_CR16","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1007\/s00417-008-0874-8","volume":"246","author":"O Sawada","year":"2008","unstructured":"Sawada O, Kawamura H, Kakinoki M, Ohji M (2008) Vascular endothelial growth factor in fellow eyes of eyes injected with intravitreal bevacizumab. Graefes Arch Clin Exp Ophthalmol 246:1379\u20131381","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2422_CR17","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/j.ophtha.2006.05.064","volume":"113","author":"RL Avery","year":"2006","unstructured":"Avery RL, Pearlman J, Pieramici DJ, Rabena MD, Castellarin AA, Nasir MA, Giust MJ, Wendel R, Patel A (2006) Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy. Ophthalmology 113:1695\u20131705","journal-title":"Ophthalmology"},{"key":"2422_CR18","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.ophtha.2007.01.017","volume":"114","author":"SJ Bakri","year":"2007","unstructured":"Bakri SJ, Snyder MR, Reid JM, Pulido JS, Singh RJ (2007) Pharmacokinetics of intravitreal bevacizumab (Avastin). Ophthalmology 114:855\u2013859","journal-title":"Ophthalmology"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-013-2422-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-013-2422-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-013-2422-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T09:29:01Z","timestamp":1688376541000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-013-2422-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,20]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["2422"],"URL":"https:\/\/doi.org\/10.1007\/s00417-013-2422-4","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,20]]}}}